enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Tildrakizumab - Wikipedia

   en.wikipedia.org/wiki/Tildrakizumab

   Tildrakizumab was approved by the Food and Drug Administration in March 2018, [2] and the European Medicines Agency in September 2018, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy. [2] [3] Tildrakizumab is administered via subcutaneous injection.

3. Secukinumab - Wikipedia

   en.wikipedia.org/wiki/Secukinumab

   Secukinumab inhibits a member of the cytokine family, interleukin 17A, which is produced mainly by inflammatory T helper 17 cells. [11] IL17A is upregulated in serum of people with psoriasis and in the synovial fluid of people with psoriatic arthritis, and promotes inflammation when it binds to the interleukin-17 receptor which is expressed in various types of cells, including keratinocytes in ...

4. Risankizumab - Wikipedia

   en.wikipedia.org/wiki/Risankizumab

   Risankizumab, sold under the brand name Skyrizi (/ s k aɪ ˈ r ɪ z i / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. [6] [7] It is designed to target interleukin 23A (IL-23A). [6] [7] [9] It is given by subcutaneous injection. [6] [7]

5. Bristol-Myers Squibb's New Psoriasis Drug Has Echoes of Humira

   www.aol.com/news/bristol-myers-squibbs-psoriasis...

   Probably not, but its new drug candidate for plaque psoriasis BMS-986165 at least has a shot to come within the same ballpark. How did Humira get to be the best-selling drug of all time, and why ...

6. Ixekizumab - Wikipedia

   en.wikipedia.org/wiki/Ixekizumab

   The most common side effects include upper respiratory infections, injection site reactions and fungal infections. [12] The drug was developed by Eli Lilly and Co. and is approved for the treatment of plaque psoriasis in the European Union and the United States as of 2016. [6] [13]

7. 3 Drugmakers Developing Revolutionary Psoriasis Treatments

   www.aol.com/2013/09/20/3-drugmakers-developing...

   For premium support please call: 800-290-4726 more ways to reach us

8. Spesolimab - Wikipedia

   en.wikipedia.org/wiki/Spesolimab

   Spesolimab, sold under the brand name Spevigo, is a monoclonal antibody used for the treatment of generalized pustular psoriasis (GPP). [4] It is an interleukin-36 receptor (IL-36R) antagonist. [ 4 ] [ 6 ] It is given via injection into a vein.

9. US FDA expands J&J's psoriasis drug for inflammatory bowel ...

   www.aol.com/news/us-fda-expands-j-js-223522601.html

   J&J has been betting on Tremfya, as its other blockbuster drug for psoriasis and ulcerative colitis, Stelara, is looking at a patent cliff — which occurs when a company loses its patent ...